Table 2.
The clinical parameter META analysis.
| Clinicopathological parameters | Studies (n) | Patients (n) | OR (95%CI) | P | I2 | PQ | Model | Pegger |
|---|---|---|---|---|---|---|---|---|
| TNM stage (III+IV vs. I+II) | 4 | 338 | 2.93 (1.80-4.77) | <0.001 | 70.00% | 0.018 | Random | 0.282 |
| Tumor invasion | 5 | 488 | 2.90 (1.90-4.41) | <0.001 | 75.90% | 0.002 | Random | 0.469 |
| Lymph node metastasis (positive vs. negative) | 5 | 488 | 2.99 (1.97-4.54) | <0.001 | 28.30% | 0.233 | Fixed | 0.918 |
| Distant metastasis (presence vs. absence) | 3 | 292 | 3.11 (1.68-5.75) | <0.001 | 92.80% | <0.001 | Random | 0.509 |
| Histologic grade (poor vs. well, moderate) | 3 | 288 | 1.00 (0.46-2.20) | 0.997 | 0.00% | 0.864 | Fixed | 0.084 |